Pinned Tweet

$BRTX announced blinded data from its Phase 2 clinical trial evaluating hypoxic-cultured mesenchymal stem cells for the treatment of chronic lumbar disc disease at the 2026 @ORSsociety Annual Meeting this weekend.
Full press release here: bit.ly/4sGF3LP
#ORS2026

English








